Phase 3 Cardiovascular Diseases Clinical Trials
12 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Cardiovascular DiseasesAtherosclerosisLipoprotein(a)
Eli Lilly and Company252 enrolled59 locationsNCT07613294
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1155 locationsNCT07064473
Recruiting
Phase 2Phase 3
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
ObesityCardiovascular DiseasesHypertension+3 more
University of Alabama at Birmingham160 enrolled1 locationNCT04971720
Recruiting
Phase 3
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Cardiovascular DiseasesDiabete Type 2
Montreal Heart Institute10,000 enrolled39 locationsNCT05633810
Recruiting
Phase 3
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
Cardiovascular DiseasesDepression
VA Office of Research and Development132 enrolled1 locationNCT04877197
Recruiting
Phase 3
Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
Cardiovascular Diseases
Penn State University65 enrolled1 locationNCT06120400
Recruiting
Phase 3
Aggressive Smoking Cessation Trial (ASAP)
Cardiovascular DiseasesAcute Coronary Syndrome
Sir Mortimer B. Davis - Jewish General Hospital798 enrolled13 locationsNCT05257629
Recruiting
Phase 3
Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery
Cardiovascular DiseasesCardiovascular ComplicationMyocardial Injury+2 more
Cantonal Hospital of St. Gallen880 enrolled1 locationNCT06279000
Recruiting
Phase 3
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Heart FailureCardiovascular DiseasesType 1 Diabetes+1 more
Steno Diabetes Center Copenhagen2,000 enrolled2 locationsNCT06082063
Recruiting
Phase 3
The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk
Cardiovascular DiseasesUric Acid
Poznan University of Medical Sciences1,116 enrolled1 locationNCT05943821
Recruiting
Phase 3
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
Heart FailureCardiovascular DiseasesHypertension+5 more
Pulnovo Medical (Wuxi) Co., Ltd.264 enrolled1 locationNCT05824923
Recruiting
Phase 3
Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
Cardiovascular DiseasesDiabetesAtherosclerosis+1 more
Ottawa Heart Institute Research Corporation115 enrolled2 locationsNCT04181996